Credit Suisse’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-70,000
Closed -$9.97M 4442
2016
Q1
$9.97M Sell
70,000
-43,127
-38% -$5.8M 0.01% 1121
2015
Q4
$16.2M Buy
113,127
+64,672
+133% +$9.74M 0.02% 888
2015
Q3
$7.12M Buy
48,455
+9,497
+24% +$1.44M 0.01% 1329
2015
Q2
$5.43M Sell
38,958
-700
-2% -$93.1K 0.01% 1668
2015
Q1
$4.92M Sell
39,658
-21,457
-35% -$2.56M 0.01% 1683
2014
Q4
$6.91M Buy
61,115
+27,815
+84% +$2.99M 0.01% 1527
2014
Q3
$3.54M Buy
+33,300
New +$3.58M ﹤0.01% 2026

Other funds holding AMSGP

Credit Suisse's AMSGP Position: Q2 2016 in Review

Credit Suisse sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q2 2016, closing a stake of 70,000 shares — an estimated $9.97M sold.

Credit Suisse first reported a position in AMSGP in Q3 2014 and held it in 7 quarters. The position peaked at $16.2M in Q4 2015. 24 funds tracked by Wall St. Rank hold AMSGP as of Q2 2016.

  • Credit Suisse reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q2 2016 after selling out during the quarter.
  • Credit Suisse sold 70,000 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q2 2016, an estimated $9.97M.
  • Credit Suisse first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2014 and held it in 7 quarters.
  • Credit Suisse's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $16.2M in Q4 2015.
  • 24 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q2 2016.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.